An Institutional experience with primary hyperparathyroidism in the elderly over two decades

Am J Surg. 2021 Sep;222(3):549-553. doi: 10.1016/j.amjsurg.2021.01.027. Epub 2021 Jan 30.

Abstract

Background: Parathyroidectomy is the only curative treatment for primary hyperparathyroidism (pHPT) and is associated with low morbidity. This study examined the severity of disease and outcomes of parathyroidectomy based on patient age at a high-volume institution.

Methods: This is a retrospective review of sporadic pHPT patients who underwent initial parathyroidectomy. To study disease severity over time, patients were divided into timeframes: 1999-2007, 2007-2012, and 2013-2018. Elderly was defined as age ≥75 years.

Results: Over time, the elderly had progressively lower preoperative calcium (11.0, 10.7, 10.7; p = 0.05) and PTH (150.4, 111.9, 107.9; p < 0.001) levels. By age, there was no difference in preoperative calcium (10.8, 10.9; p = 0.91) or in rates of recurrent laryngeal nerve injury, hypoparathyroidism, or persistent/recurrent pHPT.

Conclusions: Over the 3 time periods of the study, elderly patients had progressively lower calcium and PTH levels. There was no difference in endocrine-specific complications between the age groups, suggesting that parathyroidectomy in the elderly is safe and therefore, age-associated morbidity should not preclude parathyroidectomy.

Keywords: Elderly; Outcomes; Parathyroidectomy; Primary hyperparathyroidism.

MeSH terms

  • Age Factors
  • Aged
  • Calcium / blood
  • Female
  • Hospitals, High-Volume
  • Humans
  • Hyperparathyroidism, Primary / blood
  • Hyperparathyroidism, Primary / surgery*
  • Male
  • Parathyroid Hormone / blood
  • Parathyroidectomy* / adverse effects
  • Parathyroidectomy* / statistics & numerical data
  • Postoperative Complications / epidemiology
  • Preoperative Period
  • Recurrent Laryngeal Nerve Injuries / epidemiology
  • Retrospective Studies
  • Severity of Illness Index
  • Time Factors
  • Treatment Outcome
  • Vitamin D / analogs & derivatives
  • Vitamin D / blood

Substances

  • Parathyroid Hormone
  • Vitamin D
  • 25-hydroxyvitamin D
  • Calcium